Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Research Tools and Instruments - Category 1 (<$150,000)

University of Alberta

$62,490.00

Lung Mechanics Simulator for Testing Inhalation Drug Delivery Devices

EF 2014-15

Résumé
These funds will assist the Principal Investigator and Co-Investigator in developing representative test platforms for evaluation of devices and patient interfaces used to administer medical gases and aerosols. Use of gases in medicine comprises specialized applications in anesthesia, critical care, lung imaging, and diagnosis of respiratory disease, as well as administration of supplemental oxygen throughout the continuum of care - from home to hospital to emergency settings. Aerosol drug delivery is widespread in the treatment of respiratory diseases, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis.The most vulnerable patients receiving inhalation therapy often also receive a form of breathing support, ranging from continuous positive airway pressure to fully controlled mechanical ventilation. Several conditions affecting term and pre-term newborns fall into this category, including respiratory syncytial virus (RSV) infection, persistent pulmonary hypertension of the newborn (PPHN), and respiratory distress syndrome (RDS). The requested funds will be used to purchase instrumentation to allow us to accurately simulate lung mechanics, even of the youngest and most compromised patients, in laboratory experiments investigating interactions between gas or aerosol delivery systems and positive pressure mechanical ventilators. In combination with our existing expertise in development of realistic and idealized upper airways geometries, this added capability will provide state-of-the-art facilities for laboratory evaluation of gas and aerosol delivery to ventilated patients.
Programme
Research Tools and Instruments - Category 1 (<$150,000)
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
472410-2015
Name nom
Martin, Andrew
Department département
Mechanical Engineering
Organization id
9
Institution établissement
University of Alberta
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2014
Competition year année de concours
2015
Award amount
62490
Program id
EQPEQ
Program name en
Research Tools and Instruments - Category 1 (<$150,000)
Program name fr
Outils et instruments de recherche - catégorie 1 (<150 000$)
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1512
Committee name en
Mechanical Engineering
Committee name fr
Génie mécanique
Area of application code
518
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Medical equipment and apparatus
Area of application fr
Appareils et instruments médicaux
Research subject code
2109
Research subject group en
Mechanical engineering
Research subject group fr
Génie mécanique
Research subject en
Mechanical systems and instrumentation
Research subject fr
Instrumentation et systèmes mécaniques
Partie
1
Nb partie
1
Application title
Lung Mechanics Simulator for Testing Inhalation Drug Delivery Devices
Keyword
NSERC
Application summary
These funds will assist the Principal Investigator and Co-Investigator in developing representative test platforms for evaluation of devices and patient interfaces used to administer medical gases and aerosols. Use of gases in medicine comprises specialized applications in anesthesia, critical care, lung imaging, and diagnosis of respiratory disease, as well as administration of supplemental oxygen throughout the continuum of care - from home to hospital to emergency settings. Aerosol drug delivery is widespread in the treatment of respiratory diseases, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis.The most vulnerable patients receiving inhalation therapy often also receive a form of breathing support, ranging from continuous positive airway pressure to fully controlled mechanical ventilation. Several conditions affecting term and pre-term newborns fall into this category, including respiratory syncytial virus (RSV) infection, persistent pulmonary hypertension of the newborn (PPHN), and respiratory distress syndrome (RDS). The requested funds will be used to purchase instrumentation to allow us to accurately simulate lung mechanics, even of the youngest and most compromised patients, in laboratory experiments investigating interactions between gas or aerosol delivery systems and positive pressure mechanical ventilators. In combination with our existing expertise in development of realistic and idealized upper airways geometries, this added capability will provide state-of-the-art facilities for laboratory evaluation of gas and aerosol delivery to ventilated patients.